Philip G Tibbo
Biographic Data
| ID | 7449771 |
|---|---|
| NAME | Philip G Tibbo |
| GIVEN NAMES | Philip G |
| FAMILY NAME | Tibbo |
| SIGNATURE | TIBBO P G |
| AFFILIATIONS | Dalhousie University |
| ORCID | 0000-0002-2070-6495 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Emotional Psychopathology and Coping Cannabis Use Motives Are Involved in the Link Between Anxiety Sensitivity and Adverse Cannabis-Related Outcomes in Canadian Emerging Adults
Background: Cannabis use and related problems are prevalent among Canadian emerging adults. Investigating risk factors for cannabis use and related problems, such as personality traits, is important for earlier risk mitigation in this vulnerable population. Anxiety sensitivity (AS) is associated with adverse cannabis outcomes in emerging adults, though the mechanisms driving this effect remain unclear. Theory linking AS to cannabis use and relate…
Elevated glutamine but not glutamate is associated with clozapine eligibility in an early psychosis sample
While elevated ACC glutamate has been associated with poor response to antipsychotic medications in early psychosis samples, this is the first study to explore the association with clozapine eligibility. Contrary to our hypothesis, ACC glutamate was not higher in the CE group. However, glutamine, a precursor to glutamate, was higher in the CE group, in line with previous studies that have found elevated glutamatergic metabolites to be associated …
Strengthening the Delivery of Physical Healthcare for Adults Living With Serious Mental Illness – A Qualitative Description of Patient and Family Member Perspectives
BACKGROUND: Individuals with serious mental illness (SMI) have higher rates of comorbid physical health conditions, poorer associated health outcomes, and die on average 10-20 years earlier than the general population. This qualitative study aimed to explore the perspectives and experiences of adults living with SMI and family members with accessing physical healthcare within primary and mental health settings in Canada. METHODS: We conducted a q…
The substance use profiles of adults who sought mental health and addiction services through a centralized intake process in Nova Scotia (2020–2021)
The high prevalence of daily substance use among MHA Intake service users in Nova Scotia highlights the need for prevention and treatment strategies to address individual and structural level factors contributing to daily substance use
Pharmacotherapies for cannabis use disorder
No prominent works on this page.
Pharmacotherapies for cannabis use disorder
The substance use profiles of adults who sought mental health and addiction services through a centralized intake process in Nova Scotia (2020–2021)
The high prevalence of daily substance use among MHA Intake service users in Nova Scotia highlights the need for prevention and treatment strategies to address individual and structural level factors contributing to daily substance use
Strengthening the Delivery of Physical Healthcare for Adults Living With Serious Mental Illness – A Qualitative Description of Patient and Family Member Perspectives
BACKGROUND: Individuals with serious mental illness (SMI) have higher rates of comorbid physical health conditions, poorer associated health outcomes, and die on average 10-20 years earlier than the general population. This qualitative study aimed to explore the perspectives and experiences of adults living with SMI and family members with accessing physical healthcare within primary and mental health settings in Canada. METHODS: We conducted a q…
Emotional Psychopathology and Coping Cannabis Use Motives Are Involved in the Link Between Anxiety Sensitivity and Adverse Cannabis-Related Outcomes in Canadian Emerging Adults
Background: Cannabis use and related problems are prevalent among Canadian emerging adults. Investigating risk factors for cannabis use and related problems, such as personality traits, is important for earlier risk mitigation in this vulnerable population. Anxiety sensitivity (AS) is associated with adverse cannabis outcomes in emerging adults, though the mechanisms driving this effect remain unclear. Theory linking AS to cannabis use and relate…
Elevated glutamine but not glutamate is associated with clozapine eligibility in an early psychosis sample
While elevated ACC glutamate has been associated with poor response to antipsychotic medications in early psychosis samples, this is the first study to explore the association with clozapine eligibility. Contrary to our hypothesis, ACC glutamate was not higher in the CE group. However, glutamine, a precursor to glutamate, was higher in the CE group, in line with previous studies that have found elevated glutamatergic metabolites to be associated …
Gerontology (2 works) · Medicine (2 works) · Mental health (2 works) · Psychiatry (2 works) · Psychology (2 works) · Schizophrenia research and treatment (2 works) · Substance Abuse Treatment and Outcomes (2 works) · Addiction (1 works) · Antipsychotic (1 works) · Anxiety (1 works)